Volume 125, Issue 11

Search all Journal of Neural Transmission articles

November 2018

Special Issue: Monoamine Oxidase A and B: Eternally Enigmatic Isoenzymes

Issue Editors:

Jean Chen Shih,
Peter Riederer,
Wakako Maruyama,
Makoto Naoi

16 articles in this issue

Introduction to the special issue on monoamine oxidase A and B: eternally enigmatic isoenzymes
Jean Chen Shih
Peter Riederer
Makoto Naoi
Editorial 26 September 2018 Pages: 1517 - 1518
90 years of monoamine oxidase: some progress and some confusion
Keith F. Tipton
Neurology and Preclinical Neurological Studies - Review Article 10 April 2018 Pages: 1519 - 1551
Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy
Jean C. Shih
Psychiatry and Preclinical Psychiatric Studies - Review Article 27 September 2018 Pages: 1553 - 1566
The structure of monoamine oxidases: past, present, and future
Luca Giacinto Iacovino
Francesca Magnani
Claudia Binda
Neurology and Preclinical Neurological Studies - Review Article 24 August 2018 Pages: 1567 - 1579
Epigenetic signature of MAOA and MAOB genes in mental disorders
Christiane Ziegler
Katharina Domschke
Psychiatry and Preclinical Psychiatric Studies - Review Article 21 September 2018 Pages: 1581 - 1588
From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency
Marco Bortolato
Gabriele Floris
Jean C. Shih
Psychiatry and Preclinical Psychiatric Studies - Review Article 10 May 2018 Pages: 1589 - 1599
Gene–environment interaction of monoamine oxidase A in relation to antisocial behaviour: current and future directions
Kent W. Nilsson
Cecilia Åslund
Lars Oreland
Translational Neurosciences - Review Article Open access 07 June 2018 Pages: 1601 - 1626
Monoamine oxidase-A, serotonin and norepinephrine: synergistic players in cardiac physiology and pathology
Jeanne Mialet-Perez
Yohan Santin
Angelo Parini
Neurology and Preclinical Neurological Studies - Review Article 24 July 2018 Pages: 1627 - 1634
Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons
Makoto Naoi
Wakako Maruyama
Masayo Shamoto-Nagai
Neurology and Preclinical Neurological Studies - Review Article 26 December 2017 Pages: 1635 - 1650
An inducible MAO-B mouse model of Parkinson’s disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics
Manish Chamoli
Shankar J. Chinta
Julie K. Andersen
Neurology and Preclinical Neurological Studies - Review Article 30 April 2018 Pages: 1651 - 1658
Kinetics, mechanism, and inhibition of monoamine oxidase
Rona R. Ramsay
Alen Albreht
Neurology and Preclinical Neurological Studies - Review Article 07 March 2018 Pages: 1659 - 1683
On the practical aspects of characterising monoamine oxidase inhibition in vitro
Andrew Holt
Psychiatry and Preclinical Psychiatric Studies - Review Article 29 October 2018 Pages: 1685 - 1705
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths
Peter Kenneth Gillman
Psychiatry and Preclinical Psychiatric Studies - Review Article 25 September 2018 Pages: 1707 - 1717
Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
Moussa B. H. Youdim
Neurology and Preclinical Neurological Studies - Review Article 19 October 2018 Pages: 1719 - 1733
Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease
Éva Szökő
Tamás Tábi
Kálmán Magyar
Neurology and Preclinical Neurological Studies - Review Article 07 February 2018 Pages: 1735 - 1749
Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects
Peter Riederer
Thomas Müller
Neurology and Preclinical Neurological Studies - Review Article 22 March 2018 Pages: 1751 - 1757

Volume 125, Issue 11

Introduction to the special issue on monoamine oxidase A and B: eternally enigmatic isoenzymes

90 years of monoamine oxidase: some progress and some confusion

Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy

The structure of monoamine oxidases: past, present, and future

Epigenetic signature of MAOA and MAOB genes in mental disorders

From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency

Gene–environment interaction of monoamine oxidase A in relation to antisocial behaviour: current and future directions

Monoamine oxidase-A, serotonin and norepinephrine: synergistic players in cardiac physiology and pathology

Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons

An inducible MAO-B mouse model of Parkinson’s disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics

Kinetics, mechanism, and inhibition of monoamine oxidase

On the practical aspects of characterising monoamine oxidase inhibition in vitro

A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths

Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases

Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease

Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects

Navigation